Christopher Bunker, PhD, MBA

Alamar Biosciences

Dr. Christopher Bunker is the Vice President of Biopharma Business Development at Alamar Biosciences. Dr. Bunker did his doctoral research in Biological Chemistry at Harvard University and a Leukemia Society of America postdoctoral fellowship in molecular genetics at University of California, San Francisco. He was a senior scientist at Genome Therapeutics before joining Cell Signaling Technology at its inception in 2000. Dr. Bunker received an M.B.A from Boston University, and then joined Advanced Cell Diagnostics, where he led its assay services business for ten years. He joined Alamar Biosciences in the start of 2022.

Disclosure information not submitted.

Presentation(s):

• Industry Tutorial: Comprehensive Protein Profiling of Inflammation at Attomolar Sensitivity Provides Novel Insights into Mechanisms of Immune Response

  Thursday, June 20, 2024
  11:45 AM - 1:00 PM PT